Drug Approvals
The Drug Development Process Explained
The drug development process from laboratory research to patients: translational research, decision gates, who does what, and how a medicine reaches clinical use.
Reimbursement and access
Regulatory approval establishes that a product may be sold. Whether patients can obtain it is a separate decision, taken nationally or locally through reimbursement, health technology assessment and formulary processes — which is why an approved medicine can be unavailable in a country for years, or indefinitely.
This distinction is the one most often lost in coverage of new treatments, and it is the one that determines whether an announcement changes anything for a patient. We report both decisions and keep them apart.
Drug Approvals
What Is Drug Approval? How FDA and EMA Decide
How drug approval works: what regulators assess, how FDA and EMA review differ, expedited pathways, conditional approvals, and what happens after authorisation.
Medical Devices
Medical Device Innovation: Prototype to Clinical Use
How medical device innovation works: needs identification, prototyping, design controls, risk management, clinical evaluation, regulatory approval and adoption.
Remote Patient Monitoring
Remote Patient Monitoring: How It Changes Care
Remote patient monitoring explained: devices, clinical uses in heart failure, diabetes and hypertension, evidence, workflow design, reimbursement and risks.
Healthcare Regulation
How Healthcare Regulation Works: A Complete Guide
How healthcare regulation works: who regulates professionals, providers, medicines, devices and data, how rules are enforced, and why regulatory systems differ.
Drug Regulation
How New Medicines Are Approved: FDA and EMA Paths
FDA and EMA regulatory pathways compared: standard and expedited routes, evidence requirements, decision structures, and why approvals differ between regions.